AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Oct 3, 2017

30071_dirs_2017-10-03_2a1f1090-7afb-43dc-b8f2-13dee7044978.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-09-29

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-29	ResMed Common Stock	M	25934	$38.98	Acquired	224337	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-29	ResMed Common Stock Options	$38.98	M	25934	Disposed	2019-11-15	ResMed Common Stock (25934)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	298900	Indirect
ResMed Common Stock	136000	Indirect
ResMed Common Stock	23200	Indirect

Footnotes

F1: Transaction to exercise options and hold shares acquired through purchase.

F2: Options vest in full on (i) the first November 11 following the grant date, or (ii) the first annual shareholder's meeting following grant date.